A 68-year-old man with a 10-year history of Parkinson's disease presents to the neurology clinic complaining of worsening tremor and rigidity despite optimal levodopa therapy. His wife reports that he has also developed urinary retention and constipation over the past 3 months. On examination, he has a resting tremor, cogwheel rigidity, and a positive glabellar tap. His post-void residual urine is 180 mL. Which of the following anticholinergic agents would be most appropriate to add to his current regimen, and what is the mechanism by which it would benefit his motor symptoms?

Explanation

## Anticholinergic Drugs in Parkinson's Disease ### Mechanism of Benefit **Key Point:** In Parkinson's disease, dopamine deficiency in the striatum causes a relative excess of cholinergic activity. Anticholinergic agents restore the dopamine–acetylcholine balance by blocking muscarinic receptors, thereby reducing tremor and rigidity. ### Why Benztropine Is the Best Choice **High-Yield:** Benztropine is a tertiary amine anticholinergic that crosses the blood-brain barrier and selectively blocks M1 receptors in the basal ganglia. It is the first-line anticholinergic for Parkinson's disease, particularly effective for tremor and rigidity. **Clinical Pearl:** Benztropine has a dual mechanism—it also has weak dopamine reuptake inhibition, which provides additional symptomatic benefit beyond pure anticholinergic action. ### Anticholinergic Agents in Parkinson's: Comparison | Agent | BBB Penetration | Primary Use | Adverse Effects | | --- | --- | --- | --- | | Benztropine | Yes (tertiary amine) | Parkinson's tremor/rigidity | Urinary retention, constipation, dry mouth | | Trihexyphenidyl | Yes (tertiary amine) | Parkinson's (less common now) | Cognitive impairment, glaucoma risk | | Atropine | Poor (quaternary amine) | Peripheral anticholinergic only | Cannot treat central symptoms | | Glycopyrrolate | Poor (quaternary amine) | Peripheral anticholinergic only | Cannot cross BBB | | Scopolamine | Yes | Motion sickness, premedication | Sedation, hallucinations | **Tip:** Remember: **tertiary amines** (benztropine, trihexyphenidyl) cross the BBB; **quaternary amines** (atropine, glycopyrrolate) do not. For CNS Parkinson's symptoms, you need a tertiary amine. ### Clinical Considerations in This Case Although the patient already has urinary retention and constipation (anticholinergic side effects), the addition of benztropine at a low dose may still be justified if motor symptoms are severely limiting quality of life. However, the clinician should: 1. Optimize bowel regimen (stool softeners, increased fluids) 2. Monitor post-void residual urine 3. Consider catheterization if retention worsens 4. Educate on anticholinergic toxicity signs (confusion, hallucinations, tachycardia) **Warning:** Anticholinergics can worsen cognitive function and increase dementia risk in elderly patients; use the lowest effective dose and monitor closely. [cite:KD Tripathi 8e Ch 10]